How much funding has Precision Neuroscience raised?

Precision Neuroscience has raised $289.0M in total funding, most recently a Series C round.

Who are Precision Neuroscience's investors?

Precision Neuroscience's investors include Forepont Capital Partners, B Capital Group, General Equity Holdings, Microsoft, Alumni Ventures, Steadview Capital.

When was Precision Neuroscience founded?

Precision Neuroscience was founded in 2021.

Where is Precision Neuroscience headquartered?

Precision Neuroscience is headquartered in New York, New York, United States.

What industry is Precision Neuroscience in?

Precision Neuroscience operates in Artificial Intelligence, Healthcare, Medical Devices.

How many employees does Precision Neuroscience have?

Precision Neuroscience has 51-200 employees.

Precision Neuroscience

Precision - Precision

New York, United States · Founded 2021 · $289.0M raised

Artificial Intelligence

Healthcare

Medical Devices

Headquarters: New York, New York
Employees: 51–200
Founded: 2021
Business Model: B2B

Website: precisionneuro.io
Total Funding: $289.0M
Last Round: $102.0M Series CDec 2024
Rounds: 5

About

Precision Neuroscience is a New York-based neurotechnology company developing the Layer 7 Cortical Interface — a minimally invasive, high-bandwidth brain-computer interface. Founded 2021 by neurosurgeon Ben Rapoport and entrepreneur Michael Mager. FDA Breakthrough Device Designation.

Summary

Precision Neuroscience is an Artificial Intelligence company based in New York, United States, founded in 2021. It has raised $289.0M in total across 5 rounds, most recently a $102.0M Series C round in Dec 2024. Investors include Forepont Capital Partners, B Capital Group and General Equity Holdings.

LinkedIn X (Twitter)GitHub